Evidence map›Paper›PMID 39100997›Full record

ArticleOncology letters2024

Renal cell carcinoma preceded by a rheumatoid‑like paraneoplastic syndrome: A case report.

Yusuke Yoshimura, Tatsuya Suwabe, Katsuyuki Miki, Takayoshi Yokoyama, Kei Kono, Keiichi Kinowaki, Ikuma Kato, Yoji Nagashima, Asami Nishikori, Yasuharu Sato and 10 more

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yusuke YoshimuraNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Tatsuya SuwabeNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Katsuyuki MikiNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Takayoshi YokoyamaNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Kei KonoDepartment of Pathology, Toranomon Hospital, Tokyo 105-8470, Japan.
Keiichi KinowakiDepartment of Pathology, Toranomon Hospital, Tokyo 105-8470, Japan.
Ikuma KatoDepartment of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Yoji NagashimaDepartment of Surgical Pathology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Asami NishikoriDepartment of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama 700-8530, Japan.
Yasuharu SatoDepartment of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama 700-8530, Japan.
Shigekazu KuriharaNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Yuki ObaNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Hiroki MizunoNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Akinari SekineNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Masayuki YamanouchiNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Manabu KamiyamaDepartment of Urology, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Yasuo IshiiNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Yuki NakamuraNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Yoshifumi UbaraNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.
Naoki SawaNephrology Center, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa 213-8587, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A man with polycystic kidney disease and a history of renal transplantation at the age of 55 years developed seronegative rheumatoid arthritis (RA) at the age of 68 years. Treatment with a biological derivative led to remission; however, the patient relapsed 2 years later. After being switched to baricitinib, the patient again achieved remission. After 2 years, when the patient was aged 72 years, RA recurred, and the right native kidney became enlarged due to the presence of a large tumor. Surgical nephrectomy was performed, and the tumor was classified as renal cell carcinoma (RCC), not otherwise specified. The cancer tissue comprised sarcomatoid and rhabdoid cells with marked neutrophil infiltration, and the tumor cells were positive for interleukin-6. The patient, aged 73 years, experienced a resolution of joint pain following surgical intervention; however, they died because of systemic metastases ~10 weeks post-operation. Based on the clinical course, the RA-like lesions and subsequent RCC were considered to represent a paraneoplastic syndrome.

Indexed as

paraneoplastic syndromerenal cell carcinoma

Identifiers

PMID39100997
PMCPMC11294971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.